πŸ‡ΊπŸ‡Έ FDA
Patent

US 7892730

Compositions and methods for cancer

granted A61PA61P35/00A61P35/02

Quick answer

US patent 7892730 (Compositions and methods for cancer) held by Sagres Discovery, Inc. expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sagres Discovery, Inc.
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00, A61P35/02